Viewing Study NCT01258192


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-28 @ 10:37 PM
Study NCT ID: NCT01258192
Status: COMPLETED
Last Update Posted: 2014-07-29
First Post: 2010-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
Sponsor: Zhejiang Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None esophageal squamous cell carcinoma View
None neoadjuvant chemotherapy View
None albumin-bound paclitaxel View
None cisplatin View